Clinical trial of ilidar; a new dibenzazepine adrenergic blocking drug, in the treatment of peripheral vascular diseases and miscellaneous complaints.
D018663:Adrenergic Agents; D003984:Dibenzazepines; D016491:Peripheral Vascular Diseases / Q000628:therapy*; D013565:Sympatholytics / Q000627:therapeutic use*
D018663:Adrenergic Agents; D003984:Dibenzazepines; D013565:Sympatholytics; C004448:azapetine; C527817:dibenzazepine
SYMPATHOLYTICS/therapeutic use; VASCULAR DISEASES PERIPHERAL/therapy